山东嘉华生物科技股份有限公司2025年半年度报告摘要

Core Viewpoint - The company plans to distribute a cash dividend of RMB 0.30 per share (including tax) to all shareholders, amounting to a total of RMB 49,365,000, which represents 79.25% of the net profit attributable to shareholders for the first half of 2025 [3][7][19]. Company Overview - The company is named Shandong Jiahua Biotechnology Co., Ltd. and is listed under the stock code 603182 [5][13]. - The total share capital of the company as of June 30, 2025, is 164,550,000 shares [3][7]. Profit Distribution Plan - The proposed cash dividend distribution is based on the total share capital as of the equity distribution registration date, which will be specified in a future announcement [6][19]. - The company’s retained earnings as of June 30, 2025, amount to RMB 445,952,469.52 [7]. - The distribution plan does not require approval from the shareholders' meeting as it falls within the authorization granted at the 2024 annual shareholders' meeting [8][9]. Decision-Making Process - The board of directors approved the profit distribution plan during the sixth board meeting held on August 18, 2025, with unanimous support [10][19]. - The supervisory board also reviewed and approved the profit distribution plan, affirming its alignment with the company's performance and growth potential [11][25].